Clinical Trials
2 trialsNCT06070961 2025-06-29
FIL_FollVax22
Fondazione Italiana Linfomi - ETS
Recruiting
NCT03702231 2023-08-04
Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)
National Institutes of Health Clinical Center (CC)
Phase 2 Completed